These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 17931094

  • 21. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
    Ma S, Lin YY, He J, Rouhani FN, Brantly M, Turino GM.
    COPD; 2013 Aug; 10(4):473-81. PubMed ID: 23560990
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-Frías F, Torres M, Lara B.
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.
    Lieberman J.
    Chest; 2000 Nov; 118(5):1480-5. PubMed ID: 11083705
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B, Ferrarotti I, Miravitlles M.
    Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
    [No Abstract] [Full Text] [Related]

  • 28. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I, Miravitlles M.
    BMC Pulm Med; 2021 Mar 23; 21(1):99. PubMed ID: 33757485
    [Abstract] [Full Text] [Related]

  • 29. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM, Bashir A, Habib M, Bashir S, Habib H, Qasim MA, Shah NN, Haq E, Teckman J, Fazili KM.
    Mutat Res Rev Mutat Res; 2017 Jul 23; 773():14-25. PubMed ID: 28927525
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.
    Blanco I, Lara B, de Serres F.
    Orphanet J Rare Dis; 2011 Apr 12; 6():14. PubMed ID: 21486454
    [Abstract] [Full Text] [Related]

  • 32. Pathophysiology and treatment of alpha 1-antitrypsin deficiency.
    MacDonald JL, Johnson CE.
    Am J Health Syst Pharm; 1995 Mar 01; 52(5):481-9;quiz 544-5. PubMed ID: 7606551
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C, Dimitrov BD.
    COPD; 2010 Jun 01; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.